BSPM
$0.10
Biostar Pharmaceutic
$.03
42.86%
BSPM
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Nov 30
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when BSPM reports earnings?
Beat
Meet
Miss

Where is BSPM's stock price going from here?
Up
Flat
Down
Stock chart of BSPM
Analysts
Summary of analysts' recommendations for BSPM
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based over-the-counter products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. It also operates an herbal medicine planting base which provides it with many of its needed materials at a significantly lower cost than purchasing from third parties, and eliminates most needs for transportation.